INTRODUCTION
Although there has been remarkable progress over the past decade elucidating the cellular and molecular mechanisms of the critical early events in blood vessel development, generation of new endothelial tubes by vasculogenesis and angiogenesis (Adams and Alitalo, 2007; Carmeliet, 2005; Jin et al., 2005; Phng and Gerhardt, 2009; Strili c et al., 2009; Weinstein and Lawson, 2002) , relatively little is known about the subsequent events that create and pattern the arterial wall (Greif, 2012; Hungerford and Little, 1999; Hungerford et al., 1996; Schwartz, 1997) . A mature arterial wall typically consists of an endothelial monolayer surrounded by multiple concentric rings of smooth muscle cells (SMCs), up to a few dozen or more layers, which dominate the mature arterial wall and provide it with structural integrity and contractility, plus an outer adventitial layer consisting of fibroblasts embedded in a collagen matrix. In many arteries there are also structural specializations such as an elastic layer separating the endothelial cells (ECs) from the vascular smooth muscle cells (VSMCs), and elastic fibers embedded in the smooth muscle layer and other cellular and molecular features that structurally subdivide and pattern the smooth muscle compartment (tunica media) (Frid et al., 1994 (Frid et al., , 1997 McLean et al., 2005; Wolinsky and Glagov, 1967) . The size and pattern of the smooth muscle layer are carefully controlled in a vessel-specific manner during development, but are dysregulated in many prominent cardiovascular diseases such as aortic aneurysm, coronary artery atherosclerosis and pulmonary hypertension.
Current models of arterial wall development posit that nascent endothelial tubes recruit SMC progenitors, which can apparently arise from a variety of sources (DeRuiter et al., 1997; Esner et al., 2006; High et al., 2007; Jiang et al., 2000; Le Liè vre and Le Douarin, 1975; Majesky, 2007; Morimoto et al., 2010; Que et al., 2008; Wasteson et al., 2008; Wilm et al., 2005; Yamashita et al., 2000) and induce them to differentiate into VSMCs. Several signaling pathways have been implicated in VSMC migration or differentiation (Domenga et al., 2004; Gaengel et al., 2009; Hirschi et al., 1998; Lindahl et al., 1997; Mizugishi et al., 2005; Owens et al., 2004; Suri et al., 1996) , but how these cells are recruited and organized into a radially patterned structure with the appropriate number and identity of layers is not well understood. Here we describe the development of the pulmonary artery (PA) wall using histochemical, clonal, and genetic analysis in mice. We show that the wall is constructed radially, from the inside out, by sequential induction and recruitment of successive cell layers from surrounding mesenchymal cells, and by developmentally regulated invasion of outer layers by inner layer cells. We also show that the endothelial-specific ligand PDGF-B can initiate wall formation but provide genetic evidence that one or more other, as yet unidentified, signals also contribute to the initiation and radial patterning of the wall.
RESULTS AND DISCUSSION

Pulmonary Artery Smooth Muscle Cells Arise from Lung Mesenchyme
To elucidate the cellular and molecular events of arterial wall formation, we focused on a small region of a developing mouse artery, the left PA between the level of the carina (ca) and first branch off the left bronchus (LL1; Figure 1A ). We selected this artery because of its relatively simple structure at birth, just two and occasionally three SMC layers plus an outer adventitial layer ( Figures 1B-1D) , the ease and precision in its identification and developmental staging provided by the adjacent bronchial (A) Ventral view of whole mount lung at embryonic day (E) 12.5 immunostained for E-cadherin (airway epithelium, green) and PECAM (endothelium, red). Box, portion of left pulmonary artery (PA) investigated here, from carina (ca) to LL1 (first lateral secondary branch off left primary bronchus) (Metzger et al., 2008) . LL2 and LL3, second and third lateral secondary branches. (B and C) Longitudinal sections of left PA at E18.5 stained with hematoxylin and eosin (H&E) (B) or immunostained for a-smooth muscle actin (SMA, red), PDGFR-b (green) and counterstained with DAPI (nuclei, blue) (C). E, endothelial cell (EC) layer; 1, first (inner) smooth muscle cell (SMC) layer; 2, second SMC layer; A, adventitial cell layer. Lu, PA lumen. (D) Schematic of B and C, showing ECs (black), SMCs (red) and adventitial cells (green). (E and F) Lineage tracing using the Wt1-CreER T2 and the Tbx4-CreER T2 transgenes as indicated with the mTmG Cre reporter to determine the contribution of the mesothelium and lung mesenchyme, respectively, to the PA wall. Longitudinal sections are shown of one side of the E18.5 left PA wall stained for the Cre reporter (green) and PECAM (white), SMA (red), and DAPI (blue) to visualize the PA wall. Pregnant dams were injected with a single dose of tamoxifen (3 mg at E9.5 in E; 1.5 mg at E10.5 in F) to activate the Cre(ER) recombinase. Inset in (E) shows in the same specimen lineage-labeled cells in the lung mesothelium, outside the PA. Lineage trace of lung mesenchyme (F; also see Figure S1C ), but not mesothelium (E), labels PA wall cells, and the fraction of lineage labeled PA wall cells with the Tbx4-CreER T2 in F is similar to the overall lung mesenchyme labeling efficiency (data not shown). airways whose full branching program is known (Metzger et al., 2008) , and its involvement in devastating diseases such as pulmonary hypertension. We carried out lineage tracing with cell-and tissue-specific Cre transgenes to investigate the developmental origin of PA SMCs. Previous studies have shown that SMCs of the outflow tract of the right heart originate at least in part from neural crest (Kirby et al., 1983; Majesky, 2007) , but SMCs of more distal segments of the PA have been proposed to arise largely from lung mesothelial cells (Que et al., 2008) and ECs (Morimoto et al., 2010) by epithelial-and endothelial-to-mesenchymal transitions. However, our analysis of PA SMCs in E18.5 lungs following lineage tracing with Wilm's tumor 1 (Wt1)-CreER
T2
(mesothelium), VE-cadherin-Cre (endothelium), Wnt1-Cre (neural crest), and Sonic hedgehog-Cre (epithelium) transgenes in conjunction with the ROSA26R mTmG Cre reporter showed that mesothelium, endothelium, neural crest, and airway epithelium are not substantial sources of SMCs of the PA during this period ( Figure 1E ; Figures S1A and S1B available online; data not shown). In contrast, lineage tracing with a recently generated lung mesenchyme-specific conditional transgene Tbx4-CreER T2 (M.K., P. Bogard, and M.A.K., unpublished data; Menke et al., 2008) , induced at E10.5, resulted in substantial labeling of E18.5 PA cells expressing the SMC marker alpha-smooth muscle actin (SMA), demonstrating that Tbx4 + lung mesenchyme is a major, and possibly the sole source of PA SMCs at this stage ( Figures 1F and S1C ).
Induction of the First Layer of Arterial Smooth Muscle
At $E11, the first layer of the PA wall begins to form by a stereotyped sequence of molecular and cellular events that occur in the mesenchymal cells surrounding the nascent PA endothelial tube ( Figure 2 ). Platelet-derived growth factor receptor (PDGFR)-b is initially expressed diffusely in the proximal lung mesenchyme ( Figure 1G ), when pulmonary ECs form a widely distributed plexus (Parera et al., 2005 ; P. Bogard, M.K., R. Metzger, and M.A.K., unpublished data; Figure 1H ). But during the next day its expression begins to restrict to the group of mesenchymal cells surrounding the nascent PA endothelial tube, in the domain that will form the arterial wall ( Figures 1I, 1I ', 1I'') (see below). Beginning at $E11.5, smooth muscle markers such as SMA are induced in the PDGFR-b + cells directly contacting the PA EC tube (Figures 2A and 2B ). SMA is initially expressed at low levels and in a discontinuous fashion along the length of the PA, with more expressing cells on the lateral than the medial aspect of the vessel and localization of SMA protein initially polarized toward the side of the cell contacting the EC layer ( Figures S2A, S2B , and S2B'). Other SMC markers also initiate expression at this time including smooth muscle myosin heavy chain (SMMHC) (Miano et al., 1994) , the actin and tropomyosin binding protein SM22-alpha, and the transmembrane protein neuron glial-2 (NG2) ( Figure S2F ; data not shown). The expression of all four of these SMC markers increases over the next few days, forming a robustly labeled layer of smooth muscle (Figures 2C-2F and S2C; data not shown).
As SMC markers are induced in first layer cells, PDGFR-b expression is downregulated in these cells ( Figure S2C ) and by E18.5, expression was generally not detected in them (Figure S2D ). Permanent marking of early PDGFR-b-expressing cells with a PDGFR-b-Cre transgene (Foo et al., 2006) (Figure S1E ) labeled almost all SMA + PA wall cells at E18.5 ( Figures  1J and S1D ), including inner layer cells that do not express PDGFR-b at this time, confirming their origin from cells that initially expressed the gene.
During this period of dynamic marker expression, first layer cells reorient. Initially, at E11.5, many first layer SMA + cells and their nuclei were elongated longitudinally along the blood vessel (Figures 2A and 2B, ''alignment'') . However, over the next few days, first layer cells shortened along their longitudinal axis (Figures 2C and 2D, ''shortening'') , and by E14.5 they were circumferentially oriented ( Figures 2E, 2F , and S2E, ''reorientation''), as they are in the mature vessel. Thus, over a 3 day period (E11.5 to E14.5), the first layer of the PA wall forms by a stereotyped series of cell marker and morphogenesis events. Figures 1B, 1C , 2G, and 2H).
As the second layer is forming, cells surrounding this layer initiate a similar program to form the outer layer of the arterial wall. At $E14, these outer layer cells express PDGFR-b and are elongated longitudinally along the artery (Figures 2C and 2D) , like early first and second layer cells. However, the outer layer cells do not progress through the full program. By E18.5, they have not turned on SMC markers or downregulated PDGFR-b expression, and they have not undergone longitudinal shortening or reorientation ( Figures 1B, 1C , 2G, and 2H). Thus, outer layer cells initiate the arterial wall program but arrest early on, forming the adventitial layer of the wall. These cells do not appear to complete the program, at least not during embryogenesis.
Taken together, the results show that the PA wall is constructed radially, from the inside-out, by sequential activation of an arterial wall program in three successive cell layers.
Radial Patterning of Cell Division in the Arterial Wall
We next investigated cell division in the developing arterial wall by immunostaining for the mitotic marker phosphohistone H3 (pH3). There were two unexpected results. First, although undifferentiated progenitor cells are thought, in general, to become less proliferative as they differentiate into VSMCs (Owens et al., 2004) , we found just the opposite in the developing PA wall. The vast majority of pH3 + mitotic cells ( Figure 3A ) of the E11.5-14.5 PA wall are found in the inner ( Figure 3B ), more differentiated layers ( Figure 3C ), most in the innermost layer directly contacting the endothelial tube (layer 1). Cells that turn on SMA maintain their proliferative index, whereas the proliferative index of cells that do not declines ( Figure 3D ). Second, we found that proliferating inner layer cells undergo a developmental shift in division plane orientation. In the early stages of PA wall development (E11.5-13.5), the axis of division of cells in the inner layer (L1) was predominately (>75%) longitudinal (Figures 3E and 3F) . However, at E14.5 the axis shifts so that most ($75%) inner layer cells now divide radially (Figures 3E and 3F) . This shift is specific to the innermost layer: cells in layer two (L2) and the adventitia (A) divide exclusively longitudinally at this stage ( Figure 3F ). Below we show by clonal analysis that this shift in division plane orientation corresponds with a transition of inner layer cells to a radially invasive mode in which they enter and help populate the surrounding cell layer.
Clonal Analysis of Inner Layer Cells Reveals a Transition to a Radially Invasive Growth Mode
A clonal analysis was carried out in which individual first layer SMCs were genetically marked to track their proliferative potential and the final positions and pattern of the daughter cells ( Figure 4A ). To label first layer cells with GFP, Cre-mediated recombination was induced in transgenic SMMHC-creER T2 ,
ROSA26R
mTmG/+ embryos using a single limiting dose (0.8-1.2 mg) of tamoxifen at E11.5, a stage at which SMMHC is expressed exclusively in the first layer of the developing PA wall. This resulted in rare or no GFP + cells within the entire visualized region of the left PA, so that labeled cells likely derived from a single recombination event. The putative PA wall clones were scored only if among SMMHC-creER T2 , ROSA26R mTmG/+ littermates, there was at least one embryo without marked cells in this region. Similar experiments using a multi-color Rainbow Cre reporter ROSA26R Rb/+ (Red-Horse et al., 2010) showed that all labeled cells in individual left PAs were almost always of a single color, confirming their clonal relationship (see Experimental Procedures) . From an analysis of the size of clones between E13.5 and E18.5, we estimate the proliferation rate (doubling time) of PA SMCs as 1.0 ± 0.4 days from E12 to E14, slowing to $3.8 ± 1.9 days from E14 to E18 (Table S1) Table S1 . Daughter cells could potentially distribute in longitudinal, circumferential, and radial directions, and the cells could remain contiguous and form a coherent clone or intermingle with unmarked cells to form a dispersed clone ( Figure 4A ). At E13.5, marked cells have proliferated and many daughters have migrated extensively along the longitudinal and circumferential axes, often separating from sibling cells and intermixing with unlabeled cells (Figures 4B, 4C , 4E, and S4). All the daughter cells, however, remain within the inner, SMA + cell layer. A day later, at E14.5, this restriction to radial migration is relaxed, and daughter cells begin to invade the second layer ( Figures 4E,  S3D , S3E, and S4). Only a small percentage (12.5%) of marked first layer cells (n = 56) have invaded the second layer at E14.5, increasing to 32% by E17.5-18.5 with marked daughter cells found throughout the first and second layers ( Figures 4D, 4E , and S4; data not shown). The relaxation of the radial restriction is only partial: although marked inner layer cells migrated extensively in the first and second layers, they did not invade the developing adventitial or intimal layers at this stage ( Figure S4 ). Because there is a full (albeit immature) second layer at E14.5 ( Figures 2E and 2F ), we infer that most second layer cells arise from induction of surrounding (i.e., second layer or beyond) lung mesenchyme (see lineage analysis, Figures 1F, 1J , and S1C), rather than radial movement of inner layer cells. A classical clonal analysis of the abdominal aortic wall in adult women using X chromosome-inactivation (analyzed by PCR) as a crude clone marker suggested limited dispersal of sibling cells in most clones (Chung et al., 1998; Schwartz and Murry, 1998) , in contrast to the extensive cell migration and mixing we observe.
It will be important to revisit this study using high-resolution clone markers to determine if this difference represents a fundamental difference between the vessels, organisms, or stages of development, or a limitation of the earlier clone marking and analysis strategy.
A Gradient Model for Radial Patterning of the Pulmonary Artery Wall
Our results show that the PA wall is constructed radially, from the inside out ( Figure 5A ), by two separate but coordinated processes. One is sequential induction and recruitment of successive cell layers from surrounding mesenchymal progenitor cells. Each layer of mesenchymal cells initiates a program of gene expression and undergoes a stereotyped sequence of morphogenesis events over a 3 day period; as one muscle layer forms, the next layer initiates development. The program arrests early in the formation of the outermost layer to generate the adventitial layer. The other process is controlled invasion of the surrounding layer by inner layer cells, which initially divide and migrate extensively within the layer but later radially reorient and either migrate into the second layer or radially divide and send daughter cells into the next developing layer. Because this transition to radial invasion coincides with the switch from circumferential to primarily radial cell division, it could be that inner cells only enter an outer layer by radial cell division. Such coupling of centrifugal movement to cell division would prevent depletion of first layer cells, while supplying extra cells needed in the outer layers given their greater circumference but paradoxical dearth of proliferating cells.
We propose that a radial signaling gradient controls and coordinates the two processes ( Figure 5B ). The likely source of the signal is the endothelium, and the kinetics of its production Although layer 1 clones can expand and mix extensively within layer 1, they do not expand radially into layer 2 until E14.5. By E18.5, they have spread extensively in layers 1 and 2, but have not invaded the adventitial layer. mG, mGFP clone marker; Rb, Rainbow (multicolor) clone marker. Scale bars, 10 mm. See also Table S1 and Figures S3 and S4. and spread, and sensitivity thresholds in the responding mesenchymal cells, would dictate arterial wall identity, the sequence in which these identities arise and the pattern of cell division. Mesenchymal cells directly adjacent to the endothelium, exposed to the highest level of signal, would be the first to induce the smooth muscle program and would proliferate most. As the signal spreads, surrounding mesenchymal cells would initiate the program and begin forming the next layer. The accumulating gradient would also polarize inner layer cells and radially reorient cell division and migration to promote invasion of the , PDGFR-b (À/À) embryos at E11.5-12.5 did not show lung developmental delay or a PA phenotype (data not shown). Scale bars, 100 mm (C and E) and 10 mm (F, H, K, and M). See also Figure S5 .
Developmental Cell
Radial Construction of an Arterial Wall surrounding cell layer. The low level of signal received by the outermost mesenchymal cells would be sufficient to initiate but not complete the smooth muscle program, creating the adventitial layer.
PDGF-B Is One of Multiple Radial Patterning Signals
The ligand PDGF-B is an attractive candidate for the radial patterning signal. It has been implicated in VSMC and pericyte (vascular wall cells associated with capillaries) development (Andrae et al., 2008; Hoch and Soriano, 2003; Lindahl et al., 1997) , and it is expressed in ECs of the developing PA starting at the time the arterial wall begins to form ( Figure 5C and data not shown). Its receptors PDGFR-a and PDGFR-b are expressed in an overlapping pattern, complementary to that of PDGF-B, in the surrounding mesenchyme of the early lung ( Figures 1G, 1I , and S5A , PDGFR-b (À/À) , Tbx4-Cre) ( Figures 5L and 5M ). Taken together, results of these genetic experiments and the PDGF-B bead experiments implicate PDGF involvement in radial patterning but indicate redundancy among both the ligands and receptors.
Although it would be elegant if the radial patterning signal was a single diffusible factor, our results suggest it is an ensemble of factors, including PDGF-B and at least one other as yet unidentified signal. Multiple factors would provide flexibility in the control of vessel wall structure, important in generating the diversity of such structures and disease phenotypes (see below). And, although it is simplest to think of the factors as diffusible like PDGF-B from the beads, certain features of the process (e.g., the temporal aspect of radial SMC differentiation patterning) could be accounted for by membrane-bound signals transmitted radially via a sequential, contact-dependent (''bucket brigade'') signaling process (Feng et al., 2010; Hoglund and Majesky, 2012; Manderfield et al., 2012) .
Implications of the Radial Patterning Model for Arterial Diversity and Disease
Other blood vessels have different radial structures than the PA. For example, at the end of gestation, the left common carotid artery (CCA) and aorta have two or three times the number of smooth muscle layers as the PA, whereas the left anterior descending coronary artery has just a single layer ( Figures 1B,  1C , and 6A-6D; data not shown). An analysis of SMA expression and fate mapping of the developing left CCA showed that, as for the PA, the CCA wall forms radially from the inside-out ( Figures  6F-6J ) with inner layer cells migrating radially to contribute to outer layers (Figures 6K and 6L ). An initial clonal analysis of the descending thoracic aorta indicates that, here too, inner layer cells migrate radially to contribute to outer layers (A. Misra, L.D., and D.M.G., unpublished data). Thus, despite their differing radial structures, at least some of the same cellular mechanisms are used to form them.
An appealing idea is that vessel-specific modulation of the radial patterning signal(s) and response thresholds generate the observed differences in vessel wall sizes and structures ( Figure 6E ), and we further speculate that dysregulation of such signaling contributes to the many vascular diseases in which the radial structure of the vessel wall is altered and SMCs become highly proliferative and motile (Owens et al., 2004) , resembling the developmental state ( Figure 6O ). Indeed, conditional activation of PDGFR-b, which presumably extends and levels the PDGF signaling gradient, markedly increases the thickness of the aorta (Olson and Soriano, 2011; Figures 6M and 6N) , and targeted deletion of the PDGF-B matrix retention motif also alters vessel walls (Lindblom et al., 2003; Nyströ m et al., 2006) . It must now be a priority to identify the full set of signals that control induction of cell layers and radial invasion, and how generally these pathways and cellular mechanisms operate in development and diseases of each arterial wall. Such pathways and mechanisms would be appealing therapeutic targets for arterial wall diseases and regenerative strategies.
EXPERIMENTAL PROCEDURES Animals
All experiments with animals were approved by the IACUC at Stanford or Yale University School of Medicine. CD1 mice (Charles Rivers Laboratories) were used for wild-type analysis. PDGF-B (+/À) (Levé en et al., 1994) , PDGFR-a GFP (Hamilton et al., 2003) , (Soriano, 1994) , PDGFR-b-Cre (Foo et al., 2006) , SMMHC-CreER T2 (Wirth et al., 2008) Laboratories. The Tbx4-Cre and Tbx4-CreER T2 transgenes are lung mesenchyme-specific and induce expression of Cre reporters beginning at E10 and throughout the undifferentiated mesenchyme as well as in mesenchymal derivatives, including airway and vascular SMC, but not in airway epithelium (M.K., P. Bogard, and M.A.K., unpublished data; Menke et al., 2008) ; construction and use of the transgenes and transgenic mice will be detailed elsewhere (M.K., P. Bogard, and M.A.K., unpublished data).
Immunohistochemistry and Histology
Embryos and lungs from timed pregnancies, in which noon of the day of vaginal plug detection was designated E0.5, were dissected and fixed in 4% paraformaldehyde (PFA) for 0.5-2 hr. For hematoxylin and eosin (H&E) staining, fixed tissue was dehydrated in methanol, and paraffin sections were prepared and stained using standard protocols. For b-galactosidase activity stains, fixed whole mount lungs were incubated with bromo-chloroindolyl-galactopyranoside (X-gal, Sigma). For immunostains of whole mount lungs (Metzger et al., 2008) , fixed lungs were dehydrated serially into 100% methanol and stored at À20 C. Lungs were rehydrated and incubated with blocking solution (5% rabbit or goat serum, 0.5% Triton X-100 in PBS) and then with primary antibodies diluted in blocking solution overnight at 4 C.
On the next day, lungs were washed with blocking solution, followed by incubation with fluorescent-conjugated secondary antibodies overnight at 4 C. For signal amplification, a biotin-conjugated antibody was substituted, and then lungs were incubated with the ABC Elite reagent ( Olson and Soriano, 2011.) Note that the mutant wall has more than twice the normal number of smooth muscle layers but the normal number of elastic layers (i, e, o) (N; Olson and Soriano, 2011) , whereas in the PA there was no observable phenotype (see Figure S5D ).
(O) Changes in the radial signaling gradient may contribute to diseases characterized by vessel wall thickening or thinning. E, endothelial layer; 1-9, smooth muscle layers 1-9; Lu, vessel lumen; i, internal elastic lamina; e, elastic lamina; o, external elastic lamina. Scale bars, 10 mm.
(1:100, Biomedical Technologies), anti-SM22-alpha (1:500, Abcam), anti-PDGFR-a (1:50, R&D), anti-GFP (1:500, Abcam), anti-phosphohistone H3 (pH3; 1:100-200, Millipore), anti-acetylated tubulin (1:500, Sigma), anti-Sca1 (1:100, BD PharMingen), directly conjugated FITC or Cy3 anti-alpha-SMA (1:100-1:200, Sigma), and biotinylated anti-PDGFR-b (1:50-100, R&D). Secondary antibodies were conjugated to either Alexa À488, À555, À647 (Molecular Probes), or Dylight 649 (Jackson Labs) fluorophores or to biotin (1:250). Note that mTomato fluorescence from the unrecombined ROSA26R mTmG allele is weak in lung cryosections or methanol-treated whole mount lungs, and certainly insignificant compared to the signal from immunostains with the anti-alpha-SMA antibody directly conjugated to Cy3. To mark nuclei, tissue was stained with DAPI (1:1,000). The positions of PA wall cells were identified as located in layer 1 (L1; i.e., the cell layer adjacent to the ECs), 2 (L2; the next radial layer), or adventitia (A; the following outer layer). The identity of layer A as adventitia should be considered provisional because these cells did not detectably express Sca1 or Ptch1 lacZ , the extant adventitial markers that label adventitia of select regions of specific vessels starting late in embryogenesis (Majesky et al., 2011; Passman et al., 2008) . For quantification of marker expression profiles in PA wall layers, longitudinal confocal sections and vascular wall cells in each section were assessed as described below for phosphohistone cell counts. L1 cells of each section were numbered sequentially around the vessel and subdivided into groups of five contiguous cells. One cell was randomly selected from each group, and the marker expression was determined for this L1 cell as well as for the adjacent cell in L2 and the successive adjacent cell in A.
In Situ Hybridization
Dehydrated whole mount lungs were rehydrated into PBS with 0.1% Tween-20, permeabilized with proteinase K (10 mg/ml) and fixed again in 4% PFA with 0.2% glutaraldehyde (Sigma). Lungs were then hybridized at 68 C with digoxigenin (DIG)-labeled (Roche) probes overnight, washed extensively in saline sodium citrate solution, and incubated with alkaline phosphateconjugated anti-DIG antibodies at 4 C overnight. Nitro blue tetrazolium chloride/5-bromo-4-chloro-3 0 -indolyphosphate p-toluidine salt (NBT-BCIP) was used to detect signal, and lungs were then washed extensively with TBS/0.1% Tween-20/10 mM EDTA. Tissue sections (10-20 mm) were hybridized and stained as described (Red-Horse et al., 2010) .
Phosphohistone Cell Counts and Mitotic Axis
Whole mount lungs stained with antibodies against pH3, SMA, and PDGFRb and with DAPI were imaged by confocal fluorescence microscopy in the coronal plane to obtain longitudinal optical sections of the left PA extending from the carina to the first left lateral secondary airway branch (LL1). The longitudinal section of the left PA closest to the carina was the starting section and subsequent sections were collected every 12-20 mm ($1 cell length) until the vessel crossed LL1. Sections were considered adequate for analysis if the lumen and at least four cell lengths in the longitudinal axis of the vessel wall were visible. Sections containing wall cells visualized on previous sections were omitted. Vascular wall cells were identified as located in L1, L2, or A. This analysis included cells on the medial or lateral aspect of the blood vessel wall but excluded cells at the proximal or distal end of each vessel section because the layer these cells reside in could not be reliably determined.
Between the carina and the LL1 airway branch, the left PA curves dorsalventrally, precluding definitive assignment to a specific wall layer at the proximal or distal end of each coronal section of the vessel. For mitotic axis counts, cells were only included in the analysis if they were pH3 + and the division axis of the mitotic figure was clearly determinable. The long axis of the PA endothelium was defined as the longitudinal axis, and mitotic angles were scored relative to this axis and binned into three groups: longitudinal, radial, or 45 . However, no mitotic figures in the 45 group were observed.
An analysis of pH3-stained mitotic figures co-stained for acetylated tubulin to show the mitotic spindle confirmed the fidelity of this approach for assigning axis of division (data not shown).
Clonal Analysis SMMHC-CreER T2 mice were crossed to either ROSA26R mTmG or ROSA26R Rb (''Rainbow'') mice. A single limiting dose (0.8-1.2 mg, see below) of tamoxifen (Sigma) was injected intraperitoneally into dams at E11.5 to induce recombination. Embryos were allowed to continue development and then analyzed at E13.5-18.5. For mGFP labeled clones, whole mount lungs were dissected and stained with an anti-GFP antibody in whole mount preparations for E13.5-14.5 lungs, or in cryosections for E17.5-18.5 lungs. Each GFP + cell was counted and its specific location and layer in the left PA wall recorded, except for cells at the proximal or distal end of each vessel section, which as described above could only be assigned to a ventral or dorsal location but not a specific layer of the PA wall. For Rainbow clones, tissue was cryosectioned and imaged using fluorescent filters for each fluorophore, and each marked cell was scored for color (i.e., Cerulean, mOrange, or mCherry), position, and specific layer of the PA wall. To find conditions of very sparse and, ideally, single cell (i.e., clonal) marking of left PA SMCs we titrated down the dose of tamoxifen injected at E11.5 in preliminary experiments. In the range used here (0.8-1.2 mg), we found that $48% of SMMHC-CreER T2 , ROSA26R mTmG/+ embryos had marked cells in the PA and the rest had none. Lower doses (0.6 mg) gave no GFP + PA SMCs at E13.5 (n = 6), whereas higher doses (1.5 mg) yielded more embryos (83%) , ROSA26R Rb/+ embryos (n = 63), the PA SMCs were almost always unlabeled (59%) or labeled with just a single color (38%), confirming clonality, and only very rarely (n = 2) were multi-color (i.e., polyclonal; 3%). In these experiments, the labeled parent cell is always an inner layer SMC because expression of SMC markers (and presumably SMMHC-CreER T2 ) is limited to this layer until three days after tamoxifen injection (i.e., E14.5; see Figures 2 and S2), and analysis of clones marked at E11.5 and analyzed at E13.5 showed labeling of only inner layer cells. In embryonic studies from other groups utilizing highly active promoters driving CreER, the time window for recombination of Cre reporters is 6-48 hr following a single injection of highdose tamoxifen (1.5-3.0 mg) (Hayashi and McMahon, 2002; Nakamura et al., 2006) . We found that injection of our standard dose of tamoxifen (1.2 mg) at E10.5, instead of E11.5, resulted in no marked left PA SMCs in SMMHCCreER
T2
, ROSA26R mTmG/+ embryos at E13.5 (n = 8). Because SMMHC protein (and presumably SMMHC-CreER T2 ) is expressed in the PA SMCs at E11.5
( Figure S2F ), these findings suggest that the outer time limit for recombination in the left PA following a 1.2 mg injection is 1 day or less. Although there were no marked PA SMCs in these experiments, there were marked airway SMCs because expression of SMC markers, presumably including SMMHCCreER T2 , occurs earlier in the airways than in the vessels. Similarly for SMMHC-CreER
T2 , ROSA26R
Rb/+ embryos from dams injected with tamoxifen at E11.5, PA SMCs were almost always unlabeled or labeled with a single color, but airway SMCs invariably contained marked cells of all three colors ( Figure S3F ).
Lung Cultures and PDGF Bead Implantation
Agarose beads (Affi-Gel Blue Gel, 100-200 mesh, Bio-Rad) were washed with sterile PBS three times for 30 min each, and then incubated for one hour with a disulfide linked homodimer of PDGF-B (R&D, 200-300 ng/ml) in PBS or with PBS alone for control beads (Furuta et al., 1997) . After incubation, the beads were briefly washed and then implanted in the mesenchyme of freshly harvested E12 whole mount lungs by making a small incision in the lung mesenchyme with flame-polished tungsten needles and carefully positioning the bead. Lungs were cultured in DMEM12 with 10% FBS on 0.4 mm filters (Millipore) at the air liquid interface for 24-72 hr in a 5% CO2 incubator, then fixed with 4% PFA and immunostained as above. Lungs that did not grow normally in culture were excluded from analysis. 
Imaging
